Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020

Overview

Journal J Med Entomol

Publisher Oxford University Press

Specialty Biology

Date 2022 Feb 9

PMID 35137146

Authors

Irina Bemba

Roland Bamou

Arsene Lenga

Aline Okoko

Parfait Awono-Ambene

Christophe Antonio-Nkondjio

Affiliations

Soon will be listed here.

Abstract

Human African trypanosomiasis (HAT), despite considerable progress in the control, is still occurring in many countries in both west and central African regions. The HAT situation in the Republic of Congo has always been overshadowed by its neighbor the Democratic Republic of Congo where over 60% of all HAT cases occur. In the Republic of Congo, HAT cases have been significantly reduced to about 20 reported cases yearly and the disease is still prevalent in few foci across the country. Although continuous assessment of HAT situation in Congo is been led by the National Control Program for HAT, research on the vector, parasite, and vector control has received little attention. Because there have not been enough reviews summarizing key findings from studies conducted so far, there is still a poor understanding of the global situation of HAT in Congo. In order to achieve sustainable elimination of HAT in Congo a deep appraisal of HAT situation is required. The present study provides a review of studies conducted on HAT in the republic of Congo since the 1950s to date in order to identify gaps in knowledge and help consolidate the gains and progress towards the elimination of sleeping sickness.

Citing Articles

Understanding Sex-biases in Kinetoplastid Infections: Leishmaniasis and Trypanosomiasis.

Battistoni O, Huston R, Verma C, Pacheco-Fernandez T, Abul-Khoudoud S, Campbell A Expert Rev Mol Med. 2025; 27:e7.

PMID: 39781597 PMC: 11803520. DOI: 10.1017/erm.2024.41.

Human African Trypanosomiasis (Sleeping Sickness)-Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention.

Ortiz-Martinez Y, Kouame M, Bongomin F, Lakoh S, Henao-Martinez A Curr Trop Med Rep. 2024; 10(4):222-234.

PMID: 38939748 PMC: 11210952. DOI: 10.1007/s40475-023-00304-w.

Targeting Trypanothione Metabolism in Trypanosomatids.

Gonzalez-Montero M, Andres-Rodriguez J, Garcia-Fernandez N, Perez-Pertejo Y, Reguera R, Balana-Fouce R Molecules. 2024; 29(10).

PMID: 38792079 PMC: 11124245. DOI: 10.3390/molecules29102214.

Risk factors and prevalence of human African trypanosomiasis in individuals living in remote areas of the republic of Congo.

Elenga V, Lissom A, Elion D, Vouvoungui J, Djontu J, Boumpoutou R BMC Public Health. 2022; 22(1):2322.

PMID: 36510162 PMC: 9743764. DOI: 10.1186/s12889-022-14577-9.

References

Truc P, Mathieu-Daude F, Tibayrenc M . Multilocus isozyme identification of Trypanosoma brucei stocks isolated in central Africa: evidence for an animal reservoir of sleeping sickness in Congo. Acta Trop. 1991; 49(2):127-35. DOI: 10.1016/0001-706x(91)90060-w. View

Ebeja A, Lutumba P, Molisho D, Kegels G, Miaka mia Bilenge C, Boelaert M . [Sleeping sickness in the region of the town of Kinshasa: a retrospective analysis during the surveillance period 1996-2000]. Trop Med Int Health. 2003; 8(10):949-55. DOI: 10.1046/j.1365-3156.2003.01116.x. View

Pepin J, Khonde N, Maiso F, Doua F, Jaffar S, Ngampo S . Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial. Bull World Health Organ. 2001; 78(11):1284-95. PMC: 2560627. View

Noireau F, Cattand P . Evaluation of Testryp CATT applied to samples of dried blood for the diagnosis of sleeping sickness. Bull World Health Organ. 1991; 69(5):603-8. PMC: 2393259. View

Lehane M, Alfaroukh I, Bucheton B, Camara M, Harris A, Kaba D . Tsetse Control and the Elimination of Gambian Sleeping Sickness. PLoS Negl Trop Dis. 2016; 10(4):e0004437. PMC: 4851330. DOI: 10.1371/journal.pntd.0004437. View

Maillot L . [Varieties of Glossina palpalis in French Equatorial Africa]. Bull Soc Pathol Exot Filiales. 1953; 46(6):1066-80. View

Esterhuizen J, Rayaisse J, Tirados I, Mpiana S, Solano P, Vale G . Improving the cost-effectiveness of visual devices for the control of riverine tsetse flies, the major vectors of human African trypanosomiasis. PLoS Negl Trop Dis. 2011; 5(8):e1257. PMC: 3149014. DOI: 10.1371/journal.pntd.0001257. View

Ginoux P, Bissadidi N, Frezil J . [Complications observed in the treatment of trypanosomiasis in the Congo]. Med Trop (Mars). 1984; 44(4):351-5. View

Jansson-Lofmark R, Na-Bangchang K, Bjorkman S, Doua F, Ashton M . Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness. Antimicrob Agents Chemother. 2014; 59(2):1299-307. PMC: 4335853. DOI: 10.1128/AAC.04101-14. View

10.

Duvallet G, Stanghellini A, Saccharin C, Vivant J . [Human trypanosomiasis focus of Vavoua (Ivory Coast). A clinical, parasitological and sero-immunological survey (author's transl)]. Med Trop (Mars). 1979; 39(5):517-26. View

11.

Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U . Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet. 2009; 374(9683):56-64. DOI: 10.1016/S0140-6736(09)61117-X. View

12.

Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S . Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Clin Infect Dis. 2007; 45(11):1435-42. DOI: 10.1086/522982. View

13.

Buscher P, Mertens P, Leclipteux T, Gilleman Q, Jacquet D, Mumba-Ngoyi D . Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study. Lancet Glob Health. 2014; 2(6):e359-63. DOI: 10.1016/S2214-109X(14)70203-7. View

14.

Franco J, Cecchi G, Priotto G, Paone M, Diarra A, Grout L . Monitoring the elimination of human African trypanosomiasis: Update to 2016. PLoS Negl Trop Dis. 2018; 12(12):e0006890. PMC: 6283345. DOI: 10.1371/journal.pntd.0006890. View

15.

Simo G, Fongho P, Farikou O, Ndjeuto-Tchouli P, Tchouomene-Labou J, Njiokou F . Trypanosome infection rates in tsetse flies in the "silent" sleeping sickness focus of Bafia in the Centre Region in Cameroon. Parasit Vectors. 2015; 8:528. PMC: 4603914. DOI: 10.1186/s13071-015-1156-z. View

16.

Magnus E, Vervoort T, VAN MEIRVENNE N . A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis. Ann Soc Belg Med Trop. 1978; 58(3):169-76. View

17.

Frezil J, Coulm J . [Present concept of strategy against sleeping sickness in the Democratic Republic of Congo]. Ann Soc Belg Med Trop. 1977; 57(4-5):315-22. View

18.

Buscher P, Gilleman Q, Lejon V . Rapid diagnostic test for sleeping sickness. N Engl J Med. 2013; 368(11):1069-70. DOI: 10.1056/NEJMc1210373. View

19.

Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud M, Checchi F . Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg. 2008; 103(3):280-90. DOI: 10.1016/j.trstmh.2008.09.005. View

20.

Scott C, Frezil J, Toudic A, Godfrey D . The sheep as a potential reservoir of human trypanosomiasis in the Republic of the Congo. Trans R Soc Trop Med Hyg. 1983; 77(3):397-401. DOI: 10.1016/0035-9203(83)90172-4. View